BioLife Solutions, Inc. has grown revenue 8.1% a year over three years and 6.8% a year over five. Revenue growth, 3-year annual rate: +8.1% (Medical Instruments & Supplies median +9.8%). Revenue growth, 5-year rate: +6.8%, growth has picked up over the last three years. Years of annual history on file: 16, FY2010 to FY2025, as filed.

BLFSBioLife Solutions, Inc.

Healthcare

$38.58+50% 1Y

$38.58

$18.1552 weeks$39.24

Is it growing?

Mixed

Neither accelerating nor breaking down: revenue growing +25% year on year and operating margin widening (+20.6 points), but earnings down −1164% year on year.

2 good, 1 to watch

Revenue trend+25% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +7% a year.

Earnings trend−1164% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.

Margin direction+20.6 points operating

Trailing-twelve-month operating margin, 3.2% now against -17.4% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is BLFS growing?

BioLife Solutions, Inc. has grown revenue 8.1% a year over three years and 6.8% a year over five.

+8.1%

Revenue growth, 3-year annual rate · Medical Instruments & Supplies median +9.8% · steady growth, ahead of inflation · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: +6.8%
Revenue growth, 5-year rate · +8.1% over three · growth has picked up over the last three years
Years of annual history on file: 16
Years of annual history on file · FY2010 to FY2025, as filed

Details›